Reuters: Regulatory News: REFILE-BRIEF-Alexza announces resubmission of Adasuve NDA

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

REFILE-BRIEF-Alexza announces resubmission of Adasuve NDA Jun 22nd 2012, 13:27 Fri Jun 22, 2012 9:27am EDT BANGALORE, June 22 (Reuters) - June 22 (Reuters) - Alexza Pharmaceuticals Inc : * Announces resubmission of Adasuve NDA and provides regulatory updates on U.S. and EU submissions * Class 1 and class 2 resubmissions have targeted review periods of 2 months and 6 months, respectively

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions